PET/CT IDs neuroendocrine tumors more accurately than CT only

12/1/2011 | MolecularImaging.net

CT alone detected only 43% of Ga-68-DOTATOC/DOTANOC-positive bone lesions in patients with histologically verified neuroendocrine tumors, according to an Austrian study presented at a radiology group's meeting. The finding led researchers to advise that PET/CT -- which had a greater detection rate -- be used rather than CT only for this patient group.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX